HIF1A and gastric cancer: Therefore, analyses combining previous results may show a possible axis of action by HIF-1α and its oncogenic signaling pathway (Fig. 6), which could contribute to improvements in prognosis assessment, functional analysis, and drug-targeted therapy in the prevention and treatment of gastric cancer.